Bio-therapeutic company Orthocell has received commitments to raise $13 million from a share placement and up to a further $5 million from a share purchase plan, primarily to accelerate the commercialisation of its CelGro flagship product.
04/12/2019 - 12:05
Orthocell to raise $18m
04/12/2019 - 12:05
Related Data & Insights
-
-
Rank Company Revenue 124th Orthocell $4.3m 125th MGC Pharmaceuticals $4.2m 126th Sterling Plantations $4.2m 128th PharmAust $3.8m 129th ResApp Health $3.8m 200 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Mentioned People
Related Articles
13 Mar 2024
Arrow to raise $10m
22 Feb 2024
Orthocell to tap investors for $3.5m
19 Feb 2024
Hazer taps investors for $9m
19 Jan 2024
Appointments January 19, 2024
15 Jan 2024
Beazley joins biotech board
22 Dec 2023
Board Moves December 22, 2023
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX